Abstract
Heterozygous mutations in SPTAN1 are associated with a broad phenotypical spectrum ranging from axonal neuropathy phenotypes to neurodevelopmental phenotypes with or without epilepsy. Recently, biallelic mutations in SPTAN1 were reported as a potential cause of autosomal recessive pure hereditary spastic paraplegia (HSP). However, no further HSP cases with biallelic SPTAN1 mutations have been reported. Herein, we report the clinical and genetic findings of a patient with complicated HSP likely caused by a novel homozygous SPTAN1 mutation. A patient with complicated HSP from a consanguineous family was recruited. The proband underwent detailed neurological examinations. Homozygosity mapping was performed in the proband and her healthy sister. Whole exome sequencing was performed in the proband. Our patient had early onset motor symptoms with upper motor neuron paralysis and intellectual disability, which is compatible with complicated HSP. Genetic analysis identified a rare homozygous missense mutation in SPTAN1 (c.4162A>G, p.I1388V), which was predicted to be deleterious by in silico tools. Her healthy parents and sister all carried the heterozygous mutation. Our results provided further support for the association of biallelic SPTAN1 variants with HSP and suggested that screening for the SPTAN1 gene should be considered not only in patients with pure HSP but also in patients with complicated HSP.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Syrbe S, Harms FL, Parrini E, Montomoli M, Mutze U, Helbig KL, et al. Delineating SPTAN1 associated phenotypes: from isolated epilepsy to encephalopathy with progressive brain atrophy. Brain. 2017;140:2322–36.
Gartner V, Markello TC, Macnamara E, De Biase A, Thurm A, Joseph L, et al. Novel variants in SPTAN1 without epilepsy: an expansion of the phenotype. Am J Med Genet A. 2018;176:2768–76.
Beijer D, Deconinck T, De Bleecker JL, Dotti MT, Malandrini A, Urtizberea JA, et al. Nonsense mutations in alpha-II spectrin in three families with juvenile onset hereditary motor neuropathy. Brain. 2019;142:2605–16.
Dong HL, Chen L, Wu ZY. A novel de novo SPTAN1 nonsense variant causes hereditary motor neuropathy in a Chinese family. Brain. 2021;144:e11.
Ylikallio E, Ritari N, Sainio M, Toppila J, Kivirikko S, Tyynismaa H, et al. De novo SPTAN1 mutation in axonal sensorimotor neuropathy and developmental disorder. Brain. 2020;143:e104.
Leveille E, Estiar MA, Krohn L, Spiegelman D, Dionne-Laporte A, Dupre N, et al. SPTAN1 variants as a potential cause for autosomal recessive hereditary spastic paraplegia. J Hum Genet. 2019;64:1145–51.
Bennett V, Healy J. Organizing the diseases fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med. 2008;14:28–36.
Huang CY, Zhang C, Zollinger DR, Leterrier C, Rasband MN. An alphaII spectrin-based cytoskeleton protects large-diameter myelinated axons from degeneration. J Neurosci. 2017;37:11323–34.
Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344–7.
Hamdan FF, Saitsu H, Nishiyama K, Gauthier J, Dobrzeniecka S, Spiegelman D, et al. Identification of a novel in-frame de novo mutation in SPTAN1 in intellectual disability and pontocerebellar atrophy. Eur J Hum Genet. 2012;20:796–800.
Yavarna T, Al-Dewik N, Al-Mureikhi M, Ali R, Al-Mesaifri F, Mahmoud L, et al. High diagnostic yield of clinical exome sequencing in Middle Eastern patients with Mendelian disorders. Hum Genet. 2015;134:967–80.
Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med. 2016;18:696–704.
Saitsu H, Tohyama J, Kumada T, Egawa K, Hamada K, Okada I, et al. Dominant-negative mutations in alpha-II spectrin cause West syndrome with severe cerebral hypomyelination, spastic quadriplegia, and developmental delay. Am J Hum Genet. 2010;86:881–91.
Writzl K, Primec ZR, Strazisar BG, Osredkar D, Pecaric-Meglic N, Kranjc BS, et al. Early onset West syndrome with severe hypomyelination and coloboma-like optic discs in a girl with SPTAN1 mutation. Epilepsia. 2012;53:e106–10.
Nonoda Y, Saito Y, Nagai S, Sasaki M, Iwasaki T, Matsumoto N, et al. Progressive diffuse brain atrophy in West syndrome with marked hypomyelination due to SPTAN1 gene mutation. Brain Dev. 2013;35:280–3.
Tohyama J, Nakashima M, Nabatame S, Gaik-Siew C, Miyata R, Rener-Primec Z, et al. SPTAN1 encephalopathy: distinct phenotypes and genotypes. J Hum Genet. 2015;60:167–73.
Ream MA, Mikati MA. Clinical utility of genetic testing in pediatric drug-resistant epilepsy: a pilot study. Epilepsy Behav. 2014;37:241–8.
Rapaccini V, Esposito S, Strinati F, Allegretti M, Manfroi E, Miconi F, et al. A Child with a c.6923_6928dup (p.Arg2308_Met2309dup) SPTAN1 Mutation Associated with a Severe Early Infantile Epileptic Encephalopathy. Int J Mol Sci. 2018;19:1976–81.
Stavropoulos DJ, Merico D, Jobling R, Bowdin S, Monfared N, Thiruvahindrapuram B, et al. Whole genome sequencing expands diagnostic utility and improves clinical management in pediatric medicine. NPJ Genom Med. 2016;1:15012–20.
Terrone G, Pinelli M, Bernardo P, Parrini E, Imperati F, Brunetti-Pierri N, et al. Intrafamilial variability in SPTAN1-related disorder: From benign convulsions with mild gastroenteritis to developmental encephalopathy. Eur J Paediatr Neurol. 2020;28:237–9.
Acknowledgements
We thank the patient and her family members for their participation.
Funding
This study was supported by the Science Technology Department of Zhejiang Province (2019C03017), the Zhejiang Province Medical and Health Technology Program (Pro. nos. 2018261205 and 2018250963).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Xie, F., Chen, S., Liu, P. et al. SPTAN1 variants likely cause autosomal recessive complicated hereditary spastic paraplegia. J Hum Genet 67, 165–168 (2022). https://doi.org/10.1038/s10038-021-00975-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s10038-021-00975-1
This article is cited by
-
Spectrins: molecular organizers and targets of neurological disorders
Nature Reviews Neuroscience (2023)